Patient organisations contribute to many areas of pharmaceutical policy. In developing their organisational capacity, many turn to financial support from pharmaceutical companies, which may create conflicts of interests....
We study contract design for welfare maximization in the well-known “common agency” model introduced in 1986 by Bernheim and Whinston. This model combines the challenges of coordinating multiple principals with the...
Patient organisations contribute to many areas of pharmaceutical policy. In developing their organisational capacity, many turn to financial support from pharmaceutical companies, which may create conflicts of interests....
We study contract design for welfare maximization in the well-known “common agency” model introduced in 1986 by Bernheim and Whinston. This model combines the challenges of coordinating multiple principals with the...
|< |
< |
1 |